Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carboplatin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002509
What this trial is testing

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer

Who this might be right for
Breast Cancer
Temple University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944772
What this trial is testing

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 247
Testing effectiveness (Phase 2)Ended earlyNCT01337154
What this trial is testing

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionStage IV Non-small Cell Lung Cancer
CytRx 140
Early research (Phase 1)Study completedNCT00268905
What this trial is testing

A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors

Who this might be right for
Cancer
Eisai Inc. 64
Testing effectiveness (Phase 2)Study completedNCT03526900
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Spanish Lung Cancer Group 40
Testing effectiveness (Phase 2)Study completedNCT01402271
What this trial is testing

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
European Organisation for Research and Treatment of Cancer - EORTC 88
Post-approval studies (Phase 4)UnknownNCT02804646
What this trial is testing

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Who this might be right for
Adenocarcinoma of Lung
Anhui Provincial Hospital 100
Early research (Phase 1)Looking for participantsNCT04811703
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

Who this might be right for
Metastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more
Hospices Civils de Lyon 15
Testing effectiveness (Phase 2)Study completedNCT02107937
What this trial is testing

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian NeoplasmsOvarian Epithelial Cancer
SOTIO a.s. 136
Early research (Phase 1)Study completedNCT03579628
What this trial is testing

AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Valerio Therapeutics 33
Large-scale testing (Phase 3)Study completedNCT02027428
What this trial is testing

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Who this might be right for
Squamous Cell Carcinoma, Non-Small-Cell Lung
Celgene 427
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Early research (Phase 1)Study completedNCT00832819
What this trial is testing

E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small-cell Lung Cancer
Eisai Co., Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Large-scale testing (Phase 3)Study completedNCT00347412
What this trial is testing

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cellectar Biosciences, Inc. 903
Testing effectiveness (Phase 2)Ended earlyNCT06964165
What this trial is testing

A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 36
Large-scale testing (Phase 3)Study completedNCT00144053
What this trial is testing

A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer
West Japan Thoracic Oncology Group 450
Testing effectiveness (Phase 2)Study completedNCT02001272
What this trial is testing

EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hospices Civils de Lyon 120
Testing effectiveness (Phase 2)WithdrawnNCT00469976
What this trial is testing

Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003127
What this trial is testing

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
SWOG Cancer Research Network 57
Next Page